These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 34325544)
1. Somnolence and Dizziness During Mirogabalin Treatment in Patients With Neuropathic Pain Related to Lumbar Disease Who Switched From Pregabalin: A Retrospective Study. Akazawa T; Inoue G; Tanaka M; Umehara T; Nagai T; Oshita Y; Imura T; Miyagi M; Saito W; Sako K; Nomura S; Hiyama A; Katoh H; Sakai D; Sato M; Yoshida A; Iinuma M; Niki H; Takaso M; Watanabe M Global Spine J; 2023 Jun; 13(5):1319-1324. PubMed ID: 34325544 [TBL] [Abstract][Full Text] [Related]
2. Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study). Kimura Y; Yamaguchi S; Suzuki T; Kato J; Chiba S; Hirakawa N; Yamaguchi K; Tanabe Y; Takatsuna H; Kenyoshi Y; Shiosakai K; Sakai M; Iseki M Pain Ther; 2021 Jun; 10(1):711-727. PubMed ID: 33856660 [TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin. Yamanaka T; Takeshita K; Mochizuki T; Inoue H; Akiyama T Spine Surg Relat Res; 2023 Mar; 7(2):136-141. PubMed ID: 37041868 [TBL] [Abstract][Full Text] [Related]
4. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study. Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647 [TBL] [Abstract][Full Text] [Related]
5. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187 [TBL] [Abstract][Full Text] [Related]
6. Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain. Hutmacher MM; Frame B; Miller R; Truitt K; Merante D J Clin Pharmacol; 2016 Jan; 56(1):67-77. PubMed ID: 26073181 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of somnolence and respiratory depression induced by pregabalin and mirogabalin use and the influence of opioid treatment using the Japanese adverse drug event report database. Kato H; Koseki T; Kondo M Pharmazie; 2024 Aug; 79(7):169-172. PubMed ID: 39152553 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of mirogabalin treatment in patients with diabetic peripheral neuropathic pain: A systematic review and meta-analysis of randomised controlled trials. Alyoubi RA; Alshareef AA; Aldughaither SM; Aljaroudi AM; Alabdulwahed A; Alduraibi FM; Masoud AT; Abu-Zaid A Int J Clin Pract; 2021 May; 75(5):e13744. PubMed ID: 32991782 [TBL] [Abstract][Full Text] [Related]
9. Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study. Nakajima R; Ooba N; Kamei M; Hashiba H; Miyazaki C Expert Opin Drug Saf; 2023; 22(9):841-848. PubMed ID: 36945742 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies. Kato J; Baba M; Kuroha M; Kakehi Y; Murayama E; Wasaki Y; Ohwada S Clin Ther; 2021 May; 43(5):822-835.e16. PubMed ID: 34059327 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study. Nikaido T; Takatsuna H; Tabata S; Shiosakai K; Nakatani T; Konno SI Pain Ther; 2022 Dec; 11(4):1195-1214. PubMed ID: 35857196 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Vinik A; Rosenstock J; Sharma U; Feins K; Hsu C; Merante D; Diabetes Care; 2014 Dec; 37(12):3253-61. PubMed ID: 25231896 [TBL] [Abstract][Full Text] [Related]
13. Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study. Baba M; Kuroha M; Ohwada S; Murayama E; Matsui N Pain Ther; 2020 Jun; 9(1):261-278. PubMed ID: 32052264 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin. Kato H; Miyazaki M; Takeuchi M; Tsukuura H; Sugishita M; Noda Y; Yamada K J Pharm Health Care Sci; 2015; 1():22. PubMed ID: 26819733 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study. Miyazaki T; Matsumoto K; Sato T; Sano I; Furukawa K; Shimoyama K; Kamohara R; Suzuki M; Kondou M; Ikeda N; Tabata S; Shiosakai K; Nagayasu T; BMC Cancer; 2024 Jan; 24(1):80. PubMed ID: 38225552 [TBL] [Abstract][Full Text] [Related]
16. Pregabalin for neuropathic pain in adults. Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of Mirogabalin on Peripheral Neuropathic Pain due to Lumbar Spine Disease. Kim K; Isu T; Kokubo R; Iwamoto N; Morimoto D; Kawauchi M; Morita A Asian Spine J; 2021 Jun; 15(3):349-356. PubMed ID: 32872751 [TBL] [Abstract][Full Text] [Related]
18. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients. Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H BMC Cancer; 2021 Dec; 21(1):1319. PubMed ID: 34886831 [TBL] [Abstract][Full Text] [Related]
19. Mirogabalin besylate in the treatment of neuropathic pain. Burgess J; Javed S; Frank B; Malik RA; Alam U Drugs Today (Barc); 2020 Feb; 56(2):135-149. PubMed ID: 32163529 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Freynhagen R; Serpell M; Emir B; Whalen E; Parsons B; Clair A; Latymer M Pain Pract; 2015 Jan; 15(1):47-57. PubMed ID: 24279736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]